Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for ...

As part of this collaboration, Pfizer Healthcare India will provide educational grants in the form of fellowships for the ...

Inspired by Pfizer’s response to the COVID pandemic, Miguel Agreda ’25 brought his skills as a joint-degree MBA/MPH student ...

There’s a new coronavirus subvariant catching the attention of global doctors and researchers: it’s being called “XEC.” ...

Pharmaceutical giant Pfizer ( PFE 0.38%) stands out in this context. The company currently offers a mouthwatering 5.7% ...

Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has ...

Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Pfizer PFE in the ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with ...